We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Genomic Health, Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 219 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 221 → 0 (-221)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $2.44B → $0 (-$2.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 219

Holders
–
Holders Change
-221
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
219
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$627M
2
BlackRock
BlackRock
New York
-$276M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$187M
4
Renaissance Technologies
Renaissance Technologies
New York
-$170M
5
State Street
State Street
Massachusetts
-$98.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
176
Advisor Group
Arizona
– -$95K -1,394 Closed
GT
177
Glenmede Trust
Pennsylvania
– -$74 -1,107 Closed
SGAM
178
Smith Group Asset Management
Texas
– -$64K -950 Closed
MOACM
179
Mutual of America Capital Management
New York
– -$54K -802 Closed
LIA
180
LS Investment Advisors
Michigan
– -$48K -706 Closed
FPS
181
Fieldpoint Private Securities
Connecticut
– -$47K -699 Closed
QT
182
Quantbot Technologies
New York
– -$42K -621 Closed
Lazard Asset Management
183
Lazard Asset Management
New York
– -$39K -581 Closed
RA
184
Royce & Associates
New York
– -$37K -551 Closed
TRCT
185
Tower Research Capital (TRC)
New York
– -$35K -518 Closed
AF
186
Advisornet Financial
Minnesota
– -$34K -500 Closed
IA
187
IFP Advisors
Florida
– -$33K -493 Closed
Nisa Investment Advisors
188
Nisa Investment Advisors
Missouri
– -$33K -490 Closed
NFG
189
Next Financial Group
Texas
– -$33K -480 Closed
APA
190
American Portfolios Advisors
New York
– -$20K -295 Closed
Federated Hermes
191
Federated Hermes
Pennsylvania
– -$20K -293 Closed
TCOV
192
Trust Company of Vermont
Vermont
– -$19K -285 Closed
Daiwa Securities Group
193
Daiwa Securities Group
Japan
– -$16K -235 Closed
PO
194
Private Ocean
California
– -$15K -219 Closed
AIC
195
Ameritas Investment Company
Nebraska
– -$14K -200 Closed
CAPTRUST Financial Advisors
196
CAPTRUST Financial Advisors
North Carolina
– -$14K -200 Closed
First Manhattan
197
First Manhattan
New York
– -$13K -200 Closed
PMFA
198
Plante Moran Financial Advisors
Michigan
– -$14K -200 Closed
GI
199
Gradient Investments
Minnesota
– -$13K -195 Closed
Fidelity Investments
200
Fidelity Investments
Massachusetts
– -$11K -161 Closed
5 6 7
8
9

GHDX Hedge Fund Activity: Q4 2019 in Review

0 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2019, worth a combined $0 — down 100% from $2.44B a quarter earlier.

Sellers outnumbered buyers: 219 funds closed out of GHDX and 0 opened new positions — a net loss of 219 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $627M sold.

  • 0 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2019, down from 221 in Q3 2019.
  • Funds reported $0 of Genomic Health, Inc. stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Genomic Health, Inc. positions in Q4 2019 and 219 closed out, a net change of -219 holders.
  • The largest Genomic Health, Inc. seller in Q4 2019 was Baker Bros. Advisors, an estimated $627M sold.

Based on aggregated 13F filings for Q4 2019.